These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29885437)

  • 1. Prospects of developing a prophylactic vaccine against human lymphatic filariasis - evaluation of protection in non-human primates.
    Khatri V; Chauhan N; Vishnoi K; von Gegerfelt A; Gittens C; Kalyanasundaram R
    Int J Parasitol; 2018 Aug; 48(9-10):773-783. PubMed ID: 29885437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the efficacy of a prophylactic vaccine formulation against lymphatic filariasis.
    Chauhan N; Banerjee P; Khatri VK; Canciamille A; Gilles J; Kalyanasundaram R
    Parasitol Res; 2017 Oct; 116(10):2821-2830. PubMed ID: 28828575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the efficacy of rBmHATαc as a multivalent vaccine against lymphatic filariasis in experimental animals and optimizing the adjuvant formulation.
    Dakshinamoorthy G; Kalyanasundaram R
    Vaccine; 2013 Dec; 32(1):19-25. PubMed ID: 24211167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a multivalent vaccine against lymphatic filariasis in rhesus macaque model.
    Dakshinamoorthy G; von Gegerfelt A; Andersen H; Lewis M; Kalyanasundaram R
    PLoS One; 2014; 9(11):e112982. PubMed ID: 25401783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the Vaccine Potential of a Tetravalent Fusion Protein (
    Chauhan N; Khatri V; Banerjee P; Kalyanasundaram R
    Front Immunol; 2018; 9():1520. PubMed ID: 30013570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single multivalent vaccination boosted by trickle larval infection confers protection against experimental lymphatic filariasis.
    Joseph SK; Ramaswamy K
    Vaccine; 2013 Jul; 31(33):3320-6. PubMed ID: 23735679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivalent fusion protein vaccine for lymphatic filariasis.
    Dakshinamoorthy G; Samykutty AK; Munirathinam G; Reddy MV; Kalyanasundaram R
    Vaccine; 2013 Mar; 31(12):1616-22. PubMed ID: 23036503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large extracellular loop of tetraspanin as a potential vaccine candidate for filariasis.
    Dakshinamoorthy G; Munirathinam G; Stoicescu K; Reddy MV; Kalyanasundaram R
    PLoS One; 2013; 8(10):e77394. PubMed ID: 24146990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses of B. malayi thioredoxin (TRX) and venom allergen homologue (VAH) chimeric multiple antigen for lymphatic filariasis.
    Anugraha G; Jeyaprita PJ; Madhumathi J; Sheeba T; Kaliraj P
    Acta Parasitol; 2013 Dec; 58(4):468-77. PubMed ID: 24338307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of immunogenicity, protective efficacy of single and cocktail DNA vaccine of Brugia malayi abundant larval transcript (ALT-2) and thioredoxin peroxidase (TPX) in mice.
    Anand SB; Murugan V; Prabhu PR; Anandharaman V; Reddy MV; Kaliraj P
    Acta Trop; 2008 Aug; 107(2):106-12. PubMed ID: 18547532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immune responses to biolistic DNA vaccination of Brugia malayi abundant larval transcript-2.
    Joseph SK; Sambanthamoorthy S; Dakshinamoorthy G; Munirathinam G; Ramaswamy K
    Vaccine; 2012 Oct; 30(45):6477-82. PubMed ID: 22885273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Wuchereria bancrofti GST as a vaccine candidate for lymphatic filariasis.
    Veerapathran A; Dakshinamoorthy G; Gnanasekar M; Reddy MV; Kalyanasundaram R
    PLoS Negl Trop Dis; 2009 Jun; 3(6):e457. PubMed ID: 19513102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of immunoprophylactic efficacy of Brugia malayi transglutaminase (BmTGA) in single and multiple antigen vaccination with BmALT-2 and BmTPX for human lymphatic filariasis.
    Vanam U; Pandey V; Prabhu PR; Dakshinamurthy G; Reddy MV; Kaliraj P
    Am J Trop Med Hyg; 2009 Feb; 80(2):319-24. PubMed ID: 19190232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brugia malayi: comparison of protective immune responses induced by Bm-alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model.
    Thirugnanam S; Pandiaraja P; Ramaswamy K; Murugan V; Gnanasekar M; Nandakumar K; Reddy MV; Kaliraj P
    Exp Parasitol; 2007 Aug; 116(4):483-91. PubMed ID: 17442307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric Epitope Vaccine from Multistage Antigens for Lymphatic Filariasis.
    Anugraha G; Madhumathi J; Prince PR; Prita PJ; Khatri VK; Amdare NP; Reddy MV; Kaliraj P
    Scand J Immunol; 2015 Oct; 82(4):380-9. PubMed ID: 26179420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoadjuvant effect of diethylcarbamazine in experimental filariasis.
    Parasurama Jawaharlal JP; Rajaiah Prabhu P; Gandhirajan A; Krishnan N; Perumal K
    Int Immunopharmacol; 2015 Feb; 24(2):458-462. PubMed ID: 25576657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoprophylactic evaluation of a 37-kDa Brugia malayi recombinant antigen in lymphatic filariasis.
    Dabir P; Dabir S; Krithika KN; Goswami K; Reddy MV
    Clin Microbiol Infect; 2006 Apr; 12(4):361-8. PubMed ID: 16524413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter evaluation of a new antibody test kit for lymphatic filariasis employing recombinant Brugia malayi antigen Bm-14.
    Weil GJ; Curtis KC; Fischer PU; Won KY; Lammie PJ; Joseph H; Melrose WD; Brattig NW
    Acta Trop; 2011 Sep; 120 Suppl 1(Suppl 1):S19-22. PubMed ID: 20430004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial lipid modification enhances immunoprophylaxis of filarial abundant larval transcript-2 protein in Mastomys model.
    Sharmila S; Christiana I; Kiran P; Reddy MV; Sankaran K; Kaliraj P
    Parasite Immunol; 2013 Jul; 35(7-8):201-13. PubMed ID: 23495791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combination of two Brugia malayi filarial vaccine candidate antigens (BmALT-2 and BmVAH) enhances immune responses and protection in jirds.
    Anand SB; Kodumudi KN; Reddy MV; Kaliraj P
    J Helminthol; 2011 Dec; 85(4):442-52. PubMed ID: 21208482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.